{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:11:15Z","timestamp":1784157075191,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,9]],"date-time":"2010-01-09T00:00:00Z","timestamp":1262995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2010,1,9]],"date-time":"2010-01-09T00:00:00Z","timestamp":1262995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s10194-009-0182-7","type":"journal-article","created":{"date-parts":[[2010,1,8]],"date-time":"2010-01-08T18:49:20Z","timestamp":1262976560000},"page":"167-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome"],"prefix":"10.1007","volume":"11","author":[{"given":"Kirsti","family":"Haaland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,9]]},"reference":[{"issue":"2","key":"182_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1447-0756.2008.00762.x","volume":"34","author":"K Kato","year":"2008","unstructured":"Kato K, Okuda M, Ishikawa H, Takahashi T, Hirahara F (2008) Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected. J Obstet Gynaecol Res 34(2):242\u2013246 10.1111\/j.1447-0756.2008.00762.x, 18412789","journal-title":"J Obstet Gynaecol Res"},{"issue":"6","key":"182_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1471-0528.2004.00525.x","volume":"112","author":"R Serreau","year":"2005","unstructured":"Serreau R, Luton D, Macher MA, Delezoide AL, Garel C, Jacqz-Aigrain E (2005) Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of ten cases. BJOG 112(6):710\u2013712 10.1111\/j.1471-0528.2004.00525.x, 1:CAS:528:DC%2BD2MXmtVSgs7w%3D, 15924524","journal-title":"BJOG"},{"key":"182_CR3","unstructured":"Regional medicines information centres. Norwegian database of adverse effects"},{"issue":"Suppl 1","key":"182_CR4","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1111\/j.1526-4610.2007.00677.x","volume":"47","author":"NM Ramadan","year":"2007","unstructured":"Ramadan NM (2007) Current trends in migraine prophylaxis. Headache 47(Suppl 1):S52\u2013S57 10.1111\/j.1526-4610.2007.00677.x, 17425710","journal-title":"Headache"},{"issue":"8","key":"182_CR5","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1681\/ASN.2005121303","volume":"17","author":"M Lacoste","year":"2006","unstructured":"Lacoste M, Cai Y, Guicharnaud L et al (2006) Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: role of the renin\u2013angiotensin system. J Am Soc Nephrol 17(8):2253\u20132263 10.1681\/ASN.2005121303, 1:CAS:528:DC%2BD28XosFalt70%3D, 16790508","journal-title":"J Am Soc Nephrol"},{"key":"182_CR6","unstructured":"Norwegian Medicines Agency. Summary of product characteristics (SPC), Atacand"},{"issue":"1","key":"182_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.289.1.65","volume":"289","author":"E Tronvik","year":"2003","unstructured":"Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289(1):65\u201369 10.1001\/jama.289.1.65, 1:CAS:528:DC%2BD3sXmsVak, 12503978","journal-title":"JAMA"},{"issue":"7277","key":"182_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/bmj.322.7277.19","volume":"322","author":"H Schrader","year":"2001","unstructured":"Schrader H, Stovner LJ, Helde G, Sand T, Bovim G (2001) Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 322(7277):19\u201322 10.1136\/bmj.322.7277.19, 1:CAS:528:DC%2BD3MXps1WgtQ%3D%3D, 11141144","journal-title":"BMJ"},{"issue":"8","key":"182_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0002-9343(02)01100-2","volume":"112","author":"M Etminan","year":"2002","unstructured":"Etminan M, Levine MA, Tomlinson G, Rochon PA (2002) Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysis. Am J Med 112(8):642\u2013646 10.1016\/S0002-9343(02)01100-2, 1:CAS:528:DC%2BD38XktVCitro%3D, 12034414","journal-title":"Am J Med"},{"issue":"8","key":"182_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1526-4610.1995.hed3508470.x","volume":"35","author":"WI Bender","year":"1995","unstructured":"Bender WI (1995) ACE inhibitors for prophylaxis of migraine headaches. Headache 35(8):470\u2013471 10.1111\/j.1526-4610.1995.hed3508470.x, 1:STN:280:DyaK28%2FhvFGgsg%3D%3D, 7591740","journal-title":"Headache"},{"issue":"6","key":"182_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1291\/hypres.27.441","volume":"27","author":"K Owada","year":"2004","unstructured":"Owada K (2004) Efficacy of candesartan in the treatment of migraine in hypertensive patients. Hypertens Res 27(6):441\u2013446 10.1291\/hypres.27.441, 1:CAS:528:DC%2BD2cXntVagtLY%3D, 15253110","journal-title":"Hypertens Res"},{"issue":"6","key":"182_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1212\/WNL.55.6.754","volume":"55","author":"SD Silberstein","year":"2000","unstructured":"Silberstein SD (2000) Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55(6):754\u2013762 1:CAS:528:DC%2BD3cXntlygsLg%3D, 10993991","journal-title":"Neurology"},{"issue":"6","key":"182_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1468-1331.2006.01411.x","volume":"13","author":"S Evers","year":"2006","unstructured":"Evers S, Afra J, Frese A et al (2006) EFNS guideline on the drug treatment of migraine\u2014report of an EFNS task force. Eur J Neurol 13(6):560\u2013572 10.1111\/j.1468-1331.2006.01411.x, 1:STN:280:DC%2BD28zotFahtQ%3D%3D, 16796580","journal-title":"Eur J Neurol"},{"issue":"1","key":"182_CR14","first-page":"72","volume":"73","author":"S Modi","year":"2006","unstructured":"Modi S, Lowder DM (2006) Medications for migraine prophylaxis. Am Fam Phys 73(1):72\u201378","journal-title":"Am Fam Phys"},{"issue":"5","key":"182_CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5694\/j.1326-5377.2008.tb02028.x","volume":"189","author":"RJ Stark","year":"2008","unstructured":"Stark RJ, Stark CD (2008) Migraine prophylaxis. Med J Aust 189(5):283\u2013288 18759728","journal-title":"Med J Aust"},{"issue":"1","key":"182_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejphar.2008.04.014","volume":"588","author":"SI Sanchez","year":"2008","unstructured":"Sanchez SI, Seltzer AM, Fuentes LB, Forneris ML, Ciuffo GM (2008) Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney. Eur J Pharmacol 588(1):114\u2013123 10.1016\/j.ejphar.2008.04.014, 1:CAS:528:DC%2BD1cXmsFKltbY%3D, 18495111","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"182_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1440-1681.1998.tb02182.x","volume":"25","author":"G Guron","year":"1988","unstructured":"Guron G, Sundelien B, Wickman A, Friberg P (1988) Angiotensin-converting enzyme inhibition in piglets induces persistent renal abnormalities. Clin Exp Pharmacol Physio 25(2):88\u201391 10.1111\/j.1440-1681.1998.tb02182.x","journal-title":"Clin Exp Pharmacol Physio"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10194-009-0182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10194-009-0182-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10194-009-0182-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10194-009-0182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T20:47:57Z","timestamp":1630442877000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1007\/s10194-009-0182-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,9]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["182"],"URL":"https:\/\/doi.org\/10.1007\/s10194-009-0182-7","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,9]]},"assertion":[{"value":"26 September 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}